| 10563 | HSAP00P0000105356 | 0.4774 | 5.689 | 1.423 | 0.1742 | 0.7729 | -4.965 | CXCL13 | chemokine (C-X-C motif) ligand 13 | ENSG00000156234 | 605149 | 10563 | NM_006419 |
| 1230 | HSAP00P0000078793 | -0.3115 | 4.025 | -1.336 | 0.2004 | 0.7954 | -5.069 | CCR1 | chemokine (C-C motif) receptor 1 | ENSG00000163823 | 601159 | 1230 | NM_001295 |
| 1232 | HSAP00P0000078796 | 0.5882 | 6.13 | 1.683 | 0.1121 | 0.7049 | -4.624 | CCR3 | chemokine (C-C motif) receptor 3 | ENSG00000183625 | 601268 | 1232 | NM_001837 |
| 1234 | HSAP00P0000439923 | 1.675 | 6.039 | 4.884 | 0.0001717 | 0.09039 | 0.9428 | CCR5 | chemokine (C-C motif) receptor 5 | ENSG00000160791 | 601373, 609532, 610379, 612522 | 1234 | NM_000579 |
| 1236 | HSAP00P0000344626 | -0.7337 | 7.894 | -2.538 | 0.02209 | 0.4881 | -3.275 | CCR7 | chemokine (C-C motif) receptor 7 | ENSG00000126353 | 600242 | 1236 | NM_001838 |
| 2826 | HSAP00P0000346185 | 0.9088 | 7.775 | 2.689 | 0.01627 | 0.459 | -3.013 | CCR10 | chemokine (C-C motif) receptor 10 | ENSG00000184451 | 600240 | 2826 | NM_016602 |
| 2919 | HSAP00P0000104613 | -0.7425 | 4.687 | -1.849 | 0.08327 | 0.6629 | -4.386 | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | ENSG00000163739 | 155730 | 2919 | NM_001511 |
| 2920 | HSAP00P0000104686 | -0.2792 | 6.312 | -0.6799 | 0.5064 | 0.9285 | -5.674 | CXCL2 | chemokine (C-X-C motif) ligand 2 | ENSG00000081041 | 139110 | 2920 | BC015753 |
| 2921 | HSAP00P0000104662 | 0.8952 | 5.99 | 3.382 | 0.003864 | 0.3219 | -1.762 | CXCL3 | chemokine (C-X-C motif) ligand 3 | ENSG00000163734 | 139111 | 2921 | NM_002090 |
| 3105 | HSAP00P0000137501 | 1.195 | 9.699 | 5.813 | 2.787e-05 | 0.03573 | 2.477 | HLA-A | major histocompatibility complex, class I, A | ENSG00000229215, ENSG00000231834, ENSG00000223980, ENSG00000224320, ENSG00000227715, ENSG00000235657, ENSG00000206505, ENSG00000206503 | 106300, 142800, 608579 | 3105 | M12758 |
| 3106 | HSAP00P0000138567 | 0.9593 | 10.52 | 5.327 | 7.117e-05 | 0.05816 | 1.692 | HLA-B | major histocompatibility complex, class I, B | ENSG00000234745, ENSG00000223532, ENSG00000224608, ENSG00000228964, ENSG00000206450, ENSG00000232126 | 106300, 142830, 608579 | 3106 | J00192 |
| 3107 | HSAP00P0000138535 | 0.8399 | 10.43 | 4.216 | 0.0006746 | 0.1742 | -0.2384 | HLA-C | major histocompatibility complex, class I, C | ENSG00000204525, ENSG00000233841, ENSG00000237022, ENSG00000228299, ENSG00000206435, ENSG00000206452, ENSG00000225691 | 142840, 177900, 609423 | 3107 | BC007814 |
| 3108 | HSAP00P0000140466 | 0.5607 | 10.68 | 2.291 | 0.03609 | 0.5469 | -3.693 | HLA-DMA | major histocompatibility complex, class II, DM alpha | ENSG00000242361, ENSG00000243719, ENSG00000204257, ENSG00000242685, ENSG00000239463, ENSG00000243189, ENSG00000241394, ENSG00000243215 | 142855 | 3108 | NM_006120 |
| 3109 | HSAP00P0000140459 | 0.4153 | 6.584 | 1.821 | 0.0876 | 0.6702 | -4.427 | HLA-DMB | major histocompatibility complex, class II, DM beta | ENSG00000242092, ENSG00000234154, ENSG00000242574, ENSG00000241674, ENSG00000242386, ENSG00000226264, ENSG00000241296, ENSG00000239329 | 142856 | 3109 | NM_002118 |
| 3111 | HSAP00P0000140494 | -1.269 | 7.526 | -3.138 | 0.006437 | 0.3681 | -2.208 | HLA-DOA | major histocompatibility complex, class II, DO alpha | ENSG00000232962, ENSG00000204252, ENSG00000206292, ENSG00000230141, ENSG00000231558, ENSG00000235744, ENSG00000232957 | 142930 | 3111 | NM_002119 |
| 3113 | HSAP00P0000140503 | 1.026 | 5.595 | 2.899 | 0.01058 | 0.4155 | -2.64 | HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | ENSG00000235844, ENSG00000224103, ENSG00000231389, ENSG00000206291, ENSG00000168384, ENSG00000228163, ENSG00000229685, ENSG00000236177 | 142880 | 3113 | X00457 |
| 3115 | HSAP00P0000140537 | 0.8872 | 8.593 | 4.087 | 0.0008821 | 0.1959 | -0.4717 | HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | ENSG00000236693, ENSG00000230708, ENSG00000223865, ENSG00000215048, ENSG00000230763, ENSG00000229295, ENSG00000237710, ENSG00000226826 | 142858 | 3115 | BC015000 |
| 3116 | HSAP00P0000140610 | 0.3616 | 3.951 | 1.36 | 0.1929 | 0.7892 | -5.041 | HLA-DPB2 | major histocompatibility complex, class II, DP beta 2 (pseudogene) | NA | NA | 3116 | BC017967 |
| 3117 | HSAP00P0000140171 | 0.9539 | 7.023 | 3.081 | 0.007252 | 0.3789 | -2.312 | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | ENSG00000196735, ENSG00000206305, ENSG00000228284, ENSG00000236418, ENSG00000232062, ENSG00000225890 | 146880, 212750 | 3117 | L34085 |
| 3119 | HSAP00P0000140279 | 0.7963 | 7.992 | 3.775 | 0.001692 | 0.2523 | -1.04 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | ENSG00000206237, ENSG00000179344, ENSG00000206302, ENSG00000231286, ENSG00000233209, ENSG00000231939, ENSG00000225824 | 123400, 126200, 212750, 222100, 604305 | 3119 | U83585 |
| 3122 | HSAP00P0000140000 | 0.5344 | 6.086 | 2.033 | 0.05921 | 0.6116 | -4.107 | HLA-DRA | major histocompatibility complex, class II, DR alpha | ENSG00000204287, ENSG00000206308, ENSG00000230726, ENSG00000227993, ENSG00000228987, ENSG00000234794, ENSG00000226260 | 142860 | 3122 | NM_019111 |
| 3123 | HSAP00P0000140118 | -0.9739 | 8.696 | -3.2 | 0.005653 | 0.3537 | -2.094 | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 | ENSG00000206240, ENSG00000196126, ENSG00000206306, ENSG00000236884, ENSG00000228080, ENSG00000229074 | 126200, 142857, 180300, 181000 | 3123 | NM_002124 |
| 3127 | HSAP00P0000140040 | 0.715 | 6.431 | 2.815 | 0.01258 | 0.4336 | -2.79 | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | ENSG00000198502 | 604776 | 3127 | M15992 |
| 3133 | HSAP00P0000137750 | 1.271 | 7.677 | 4.768 | 0.0002171 | 0.1005 | 0.7417 | HLA-E | major histocompatibility complex, class I, E | ENSG00000236632, ENSG00000204592, ENSG00000230254, ENSG00000225201, ENSG00000233904, ENSG00000229252, ENSG00000206493 | 143010 | 3133 | BX538084 |
| 3134 | HSAP00P0000137293 | 0.9861 | 11.2 | 2.929 | 0.009928 | 0.4105 | -2.585 | HLA-F | major histocompatibility complex, class I, F | ENSG00000237508, ENSG00000137403, ENSG00000229698, ENSG00000234487, ENSG00000235220, ENSG00000206509, ENSG00000204642 | 143110 | 3134 | AY216682 |
| 3135 | HSAP00P0000137393 | 0.7868 | 7.307 | 4.167 | 0.0007463 | 0.182 | -0.3263 | HLA-G | major histocompatibility complex, class I, G | ENSG00000235680, ENSG00000230413, ENSG00000233095, ENSG00000237216, ENSG00000235346, ENSG00000206506, ENSG00000204632 | 142871, 600807 | 3135 | AF071019 |
| 3459 | HSAP00P0000151856 | 0.7351 | 4.774 | 1.524 | 0.1474 | 0.7484 | -4.838 | IFNGR1 | interferon gamma receptor 1 | ENSG00000027697 | 107470, 209950, 600263, 607948, 610424 | 3459 | BC005333 |
| 3569 | HSAP00P0000158552 | 0.8447 | 5.716 | 2.258 | 0.03845 | 0.5546 | -3.747 | IL6 | interleukin 6 (interferon, beta 2) | ENSG00000136244 | 108010, 125853, 147620, 148000, 166710, 266600, 604302 | 3569 | NM_000600 |
| 3627 | HSAP00P0000105067 | -0.3487 | 3.993 | -1.455 | 0.1651 | 0.7649 | -4.924 | CXCL10 | chemokine (C-X-C motif) ligand 10 | ENSG00000169245 | 147310 | 3627 | NM_001565 |
| 4283 | HSAP00P0000105058 | 1.071 | 4.58 | 4.788 | 0.0002083 | 0.09867 | 0.7771 | CXCL9 | chemokine (C-X-C motif) ligand 9 | ENSG00000138755 | 601704 | 4283 | NM_002416 |
| 4790 | HSAP00P0000107716 | 0.4392 | 8.206 | 1.65 | 0.1188 | 0.7139 | -4.67 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | ENSG00000109320 | 164011 | 4790 | NM_003998 |
| 4791 | HSAP00P0000223451 | 0.5103 | 10.36 | 2.275 | 0.03719 | 0.5507 | -3.718 | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | ENSG00000077150 | 164012 | 4791 | NM_002502 |
| 567 | HSAP00P0000303714 | -0.6745 | 8.201 | -1.132 | 0.2744 | 0.8419 | -5.293 | B2M | beta-2-microglobulin | ENSG00000166710 | 109700, 241600 | 567 | NM_004048 |
| 58191 | HSAP00P0000334868 | -0.4875 | 10.73 | -1.776 | 0.09508 | 0.6818 | -4.493 | CXCL16 | chemokine (C-X-C motif) ligand 16 | ENSG00000161921 | 605398 | 58191 | NM_022059 |
| 5971 | HSAP00P0000384715 | 1.374 | 5.789 | 4.003 | 0.001051 | 0.2096 | -0.6245 | RELB | v-rel reticuloendotheliosis viral oncogene homolog B | ENSG00000104856 | 604758 | 5971 | M83221 |
| 6346 | HSAP00P0000342470 | -0.6546 | 6.14 | -2.348 | 0.03224 | 0.5337 | -3.598 | CCL1 | chemokine (C-C motif) ligand 1 | ENSG00000108702 | 182281 | 6346 | NM_002981 |
| 6348 | HSAP00P0000343187 | -0.75 | 6.284 | -2.967 | 0.009179 | 0.4024 | -2.517 | CCL3 | chemokine (C-C motif) ligand 3 | ENSG00000006075 | 182283, 609423 | 6348 | D63785 |
| 6352 | HSAP00P0000342939 | 0.6914 | 9.038 | 2.583 | 0.02017 | 0.4787 | -3.197 | CCL5 | chemokine (C-C motif) ligand 5 | ENSG00000161570 | 187011 | 6352 | NM_002985 |
| 6354 | HSAP00P0000342413 | 0.6492 | 7.375 | 2.51 | 0.02339 | 0.4957 | -3.324 | CCL7 | chemokine (C-C motif) ligand 7 | ENSG00000108688 | 158106 | 6354 | NM_006273 |
| 6355 | HSAP00P0000342437 | 1.126 | 5.169 | 2.62 | 0.01871 | 0.4709 | -3.133 | CCL8 | chemokine (C-C motif) ligand 8 | ENSG00000108700 | 602283 | 6355 | Y16645 |
| 6357 | HSAP00P0000342447 | 0.901 | 6.991 | 2.565 | 0.0209 | 0.4818 | -3.228 | CCL13 | chemokine (C-C motif) ligand 13 | ENSG00000181374 | 601391 | 6357 | NM_005408 |
| 6362 | HSAP00P0000343055 | 1.138 | 10.14 | 3.259 | 0.004994 | 0.3419 | -1.986 | CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | ENSG00000006074 | 603757 | 6362 | NM_002988 |
| 6363 | HSAP00P0000194800 | 0.6189 | 6.159 | 2.384 | 0.03006 | 0.5251 | -3.538 | CCL19 | chemokine (C-C motif) ligand 19 | ENSG00000172724 | 602227 | 6363 | NM_006274 |
| 6364 | HSAP00P0000070566 | 0.7714 | 4.105 | 2.255 | 0.03871 | 0.5554 | -3.752 | CCL20 | chemokine (C-C motif) ligand 20 | ENSG00000115009 | 601960 | 6364 | BC020698 |
| 6368 | HSAP00P0000343054 | 1.04 | 5.428 | 3.428 | 0.003505 | 0.3133 | -1.677 | CCL23 | chemokine (C-C motif) ligand 23 | ENSG00000167236 | 602494 | 6368 | NM_005064 |
| 6372 | HSAP00P0000104592 | -0.4498 | 4.207 | -1.218 | 0.2411 | 0.8234 | -5.203 | CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | ENSG00000124875 | 138965 | 6372 | NM_002993 |
| 6373 | HSAP00P0000105085 | 0.5726 | 4.268 | 1.639 | 0.121 | 0.7167 | -4.685 | CXCL11 | chemokine (C-X-C motif) ligand 11 | ENSG00000169248 | 604852 | 6373 | BC012532 |
| 7040 | HSAP00P0000382779 | 0.7842 | 8.48 | 2.832 | 0.01214 | 0.4288 | -2.76 | TGFB1 | transforming growth factor, beta 1 | ENSG00000105329 | 131300, 190180, 219700 | 7040 | NM_000660 |
| 7046 | HSAP00P0000200582 | -0.3909 | 5.46 | -1.419 | 0.1752 | 0.774 | -4.969 | TGFBR1 | transforming growth factor, beta receptor 1 | ENSG00000106799 | 132800, 190181, 608967, 609129, 609192 | 7046 | AJ619019 |
| 7124 | HSAP00P0000138832 | 0.6645 | 6.599 | 2.097 | 0.05244 | 0.5954 | -4.006 | TNF | tumor necrosis factor | ENSG00000228978, ENSG00000232810, ENSG00000204490, ENSG00000228321, ENSG00000228849, ENSG00000230108, ENSG00000206439, ENSG00000223952 | 157300, 191160, 248310, 600807, 611162 | 7124 | NM_000594 |
| 717 | HSAP00P0000139418 | -0.5475 | 7.21 | -2.418 | 0.02807 | 0.5168 | -3.48 | C2 | complement component 2 | ENSG00000166278, ENSG00000235017, ENSG00000231543, ENSG00000206372, ENSG00000235696, ENSG00000204364, ENSG00000226560 | 217000, 603075, 613927 | 717 | BX537504 |
| 718 | HSAP00P0000369616 | 1.031 | 7.831 | 3.8 | 0.001605 | 0.2464 | -0.9941 | C3 | complement component 3 | ENSG00000125730 | 120700, 611378, 612925, 613779 | 718 | NM_000064 |
| 719 | HSAP00P0000256516 | 0.6232 | 5.494 | 1.995 | 0.06356 | 0.6226 | -4.166 | C3AR1 | complement component 3a receptor 1 | ENSG00000171860 | 605246 | 719 | NM_004054 |
| 728 | HSAP00P0000386123 | 0.6333 | 9.277 | 2.802 | 0.01291 | 0.4367 | -2.813 | C5AR1 | complement component 5a receptor 1 | ENSG00000197405 | 113995 | 728 | NM_001736 |
| 942 | HSAP00P0000087853 | 0.3687 | 4.061 | 1.606 | 0.128 | 0.7251 | -4.728 | CD86 | CD86 molecule | ENSG00000114013 | 601020 | 942 | NM_175862 |